• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Alnylam Pharmaceuticals

Alnylam Pharmaceuticals

  1. All
  2. 3rd Party
  1. The Medicines Company Announces Positive Top-Line Results from Day 180 Interim Analysis in Ongoing ORION-1 Phase 2 Study of Inclisiran (formerly, PCSK9si)

    The Medicines Company Announces Positive Top-Line Results from Day 180 Interim Analysis in Ongoing ORION-1 Phase 2 Study of Inclisiran (formerly, PCSK9si)

  2. Dodge & Cox Balanced Fund Isn't for Everyone

    This Gold-rated fund is not a safe choice, but it's a strong one for the right kind of investor.

  3. Investing in Hidden Assets

    Use this screen to find high-growth businesses that have big ideas to keep competitors at bay.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.